Dow Down1.07% Nasdaq Down1.22%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
0.50 Down 0.00(0.34%) 10:31AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Total Revenue 670   683   854   854  
Cost of Revenue -   -   -   -  
Gross Profit 670   683   854   854  
Operating Expenses
Research Development7,628  5,259  6,302  4,512  
Selling General and Administrative4,382  3,994  5,175  5,111  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,340) (8,570) (10,623) (8,769)
Income from Continuing Operations
Total Other Income/Expenses Net(4)1,782  1,907  (120)
Earnings Before Interest And Taxes(11,344)(6,788)(8,716)(8,889)
Interest Expense234  233  233  239  
Income Before Tax(11,578)(7,021)(8,949)(9,128)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(11,578)(7,021)(8,949)(9,128)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (11,578) (7,021) (8,949) (9,128)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (11,578) (7,021) (8,949) (9,128)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.